Treace Medical Concepts Inc

Treace Medical Concepts Inc

TMCI

Get informed when a big investor buys or sells

+ Follow
Market Cap$301.66M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Treace Medical Concepts IncTreace Medical Concepts Inc-5--88%1.60.2
$-1.41

Current Fair Value

129% downside

Overvalued by 129% based on the discounted cash flow analysis.

Share Statistics

Market cap$301.66 Million
Enterprise Value$302.14 Million
Dividend Yield$- (-)
Earnings per Share$-0.93
Beta1.4
Outstanding Shares65,049,844

Return

Return on Equity-87.86%ROE
Return on Assets-32.87%
Return on Invested Capital-40.02%

Valuation & Multiples

P/E Ratio-5P/E Ratio
PEG57.04PEG
Price to Sales1.63Price to Sales
Price to Book Ratio4.88Price to Book Ratio
Enterprise Value to Revenue1.47
Enterprise Value to EBIT-5.41
Enterprise Value to Net Income-6
Total Debt to Enterprise0.04
Debt to Equity0.19Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 7, 2026
EPS Estimate
$-0.30
Average shareholder expectation
Revenue Estimate
$44.02 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$-0.26
Average shareholder expectation
Revenue Estimate
$47.71 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls105,500 Infinity%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %49.41% 6.30%
Total Invested$127.94M 164.88%
Investors Holding122 5.00%

ESG Score

No data

About Treace Medical Concepts Inc

133 employees

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion ...